DSCAX

Cian O Curnain

Cian O Curnain is an award winner product designer student who has recently completed his product design degree in TU Dublin. Having entered the Bolton Trust Student Enterprise competition in 2020, he received first place along with his team Remedy for the creation and development of the innovative product: PSAid. This win eventually led to the company participating in Stage Two, Europe’sfirst international university enterprise competition. He is a creative, innovative and driven product designer who operates optimally as part of a team. His interests include: Medical Devices, Design for Sustainability, and Assistive Design.

Hearo

Hearo is a hearing protection solution, whichallows for the user to control the volume of external audio which passes through the earusing audio limitation This will prevent the individual from experiencing dangerous levels of audio for long periods of time throughout a given audio-based activity .To achieve this the device will consist of two parts: the earpieces and the control case. When the control case is deactivated, the earpieces will keep incoming audio levels at a minimum using passive noise cancellation. When the user wishes to increase the volume to perceive higher levels of surrounding audio, they can increase the volume using the control case. This functionality relies on an internal audio limiter which adjusts the threshold of the surrounding audio. The control case includes a metal clip to allow for the user to fix the device to their waist, acting as a wearable. This allows for direct and easy contact to be made with the threshold dial when the levels of surrounding audio is to be adjusted. It also allows for the earpieces to be securely stored within the case when not in use. The primary target user for the Hearo earplugs will be musicians and other individuals who are involved in the music industry. Research has shown that many people within this sector will refrain from using hearing protection when engaging with damaging levels of audio. This is due to a stigma that has developed around this subject over recent years. Many individuals also fear that the use of passive noise cancellation products will refrain them from perceivingthe optimal quality of surrounding audios. With Hearo, the user can essentially control the volume of their hearing, as they are allowing for reduced, and controlled levels of audio to enter through the hearing protective device.

PSAid

PSAidis an at home PSA level monitoring device currently in the final stages of development. Our product enables customers to keep track of their PSA levels from the comfort of their own home and view their results on an accompanying app. This avoids the high costs associated with the time-consuming process of having PSA levels monitored in hospitals. In the box, patients will find everything they need to obtain a quantitative PSA result whilst having any influential factors considered. Once the sample is inserted into the device, the colour light sensor will measure the level of PSA in the sample and provide this result within 10 minutes. The result will be sent to the patients’ phone via Wi-Fi and can be viewed on the PSAid application. The test results obtained will be shared with the patient’s doctor via our secure server and the doctor will advise the patient on any follow up steps to be taken via the app. The colour light sensor that provides the test result will be purchased online and connected to a PCB where the data will be interpreted and sent to the app. Remedy Ltd. aims to resolve the difficulties faced by prostate cancer patients in monitoring their PSA levels post diagnosis. PSA (Prostate Specific Antigen) levels are a key indicator in
determining the stage a patient’s prostate cancer is at, therefore, keeping a close eye on a patient’s PSA levels post diagnosis is vital in preventing development of the illness into terminal metastatic prostate cancer. Currently, patients must travel to their doctor frequently to have their PSA levels monitored. This causes issues for many prostate cancer patients who suffer from side effects such as incontinence and they find it difficult to sit for long periods of time. PSA level monitoring from home is an option but it is inefficient due to long wait times for results, high cost and inaccuracy. This is costly for both the patient and the already overburdened healthcare system. Current home PSA testing lacks quantitative results, takes days for results to process and is an unsustainable means of PSA monitoring due to the throwaway nature of current devices. Remedy have received first place in the Bolton Trust student enterprise competition with the PSAid. This then led the company to competing in the German-based, Stage Two competition, Europes first international university enterprise competition.